“Opsona Therapeutics – a drug development firm founded in Trinity College – has been awarded a grant of almost €6m by the European Commission to advance clinical trials for a promising treatment for kidney transplant patients. The grant is the largest ever awarded under the EU’s FP7 programme, which funds collaborative clinical trials …” (more)
[John Mulligan, Independent, 6 May]